Background Coronavirus disease (COVID-19) is a serious infectious disease that causes
severe respiratory illness. This pandemic represents a serious public health risk. Therefore …

White blood cells activated by either a pathogen or as part of a systemic inflammatory
disease are characterized by high energy consumption and are therefore taking up the …

Soon after reports of a novel coronavirus capable of causing severe pneumonia surfaced in
late 2019, expeditious global spread of the Severe Acute Respiratory Distress Syndrome …

Dear Sir, By February 27, 2020, COVID-19 had infected about 82,163 people and killed
2800 in about 37 countries and regions [1]. The coronavirus, like SARS-CoV-2 and MERS …

Tigecycline is regarded as the last line of defense to combat multidrug-resistant Klebsiella
pneumoniae. However, increasing utilization has led to rising drug resistance and treatment …

Abstract Coronavirus disease 2019 (COVID-19) was first discovered after unusual cases of
severe pneumonia emerged by the end of 2019 in Wuhan (China) and was declared a …

While not conventionally used as the first-line modality,[18 F]-2-fluoro-2-deoxy-D-glucose
(FDG)-positron emission tomography/computed tomography (PET/CT) can identify infection …

The current outbreak of coronavirus SARS-CoV-2 has reached multiple countries worldwide.
While the number of newly diagnosed cases and fatalities is rising quickly, far-reaching …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in an ongoing global pandemic of coronavirus disease 2019 (COVID-19). The …

Abstract Coronavirus disease 2019 (COVID-19) was discovered after unusual cases of
severe pneumonia emerged in December 2019 in Wuhan Province (China). Coronavirus is …